Brussels - Delayed Quote EUR
UCB SA (UCB.BR)
At close: 5:37 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
761,000.00
761,000.00
1,119,000.00
1,553,000.00
1,081,000.00
--
Investing Cash Flow
-440,000.00
-440,000.00
-1,580,000.00
-487,000.00
-2,228,000.00
--
Financing Cash Flow
-308,000.00
-308,000.00
70,000.00
-1,119,000.00
1,177,000.00
--
End Cash Position
861,000.00
861,000.00
859,000.00
1,244,000.00
1,303,000.00
--
Capital Expenditure
-316,000.00
-316,000.00
-371,000.00
-493,000.00
-349,000.00
--
Issuance of Capital Stock
--
--
--
--
150,000.00
--
Issuance of Debt
597,000.00
597,000.00
1,025,000.00
--
1,895,000.00
--
Repayment of Debt
-424,000.00
-424,000.00
-546,000.00
-716,000.00
-416,000.00
--
Repurchase of Capital Stock
-40,000.00
-40,000.00
-42,000.00
-60,000.00
-106,000.00
--
Free Cash Flow
445,000.00
445,000.00
748,000.00
1,060,000.00
732,000.00
--
12/31/2019 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TUB.BR Financière de Tubize SA
139.60
-1.97%
ARGX.BR argenx SE
520.60
+1.64%
ARGX argenx SE
564.36
+0.70%
ASND Ascendis Pharma A/S
127.96
-0.55%
XENE Xenon Pharmaceuticals Inc.
42.75
-3.30%
IVA.PA Inventiva S.A.
2.6350
+0.19%
GLPG.AS Galapagos NV
28.02
-0.28%
FTD.SG Financière de Tubize SA
141.60
-0.84%
BIOS.BR BioSenic S.A.
0.0130
+30.00%
APGE Apogee Therapeutics, Inc.
51.81
-2.19%